References
- Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer 2009;45:992–1005
- Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med 1985;313:270–3
- Surveillance, Epidemiology, and End Results (SEER) Programme (Available from: www.seer.cancer.gov) SEER* Stat Database: incidence-SEER 9 Regs Public-Use. Nov 2005 Sub (1973–2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer statistics Branch, released April 2006, based on November 2005 submission
- Loren AW, Mangu PB, Beck LN, et al.; American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J ClinOncol 2013;31:2500–10
- Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril 2013;99:1476–84
- Friedler S, Koc O, Gidoni Y, et al. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril 2012;97:125–33
- Stroud JS, Mutch S, Rader J, et al. Effect of cancer treatment on ovarian function. Fertil Steril 2009;92:417–27
- Von Wolff M, Montag M, Dittrich R, et al. Fertility preservation in women – a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstetr 2011;284:427–35
- Practice Committees of American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013;99:37–43
- Tarlatzis BC, Fauser BC, Kolibianakis EM, et al. GnRH anatgonists in ovarian stimulation for IVF. Hum Reprod Update 2006;12:333–40
- Madrigrano A, Westphal L, Wapnir I. Egg retrieval with cryopreservation does not delay breast cancer treatment. Am J Surg 2007;194:477–81
- Anderson RA, Kinniburgh D, Baird DT. Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment. Hum Reprod 1999;14:2665–8
- von Wolff M, Thaler CJ, Frambach T, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2009;92:1360–5
- Sonmezer M, Turkcuogli I, Coskun U, Oktay K. Random start controlled ovarian hyperstimulation for emergency fertility presrvation in letrozolecycles. Fertil Steril 2011;95:2125
- Cakmak H, Katz A, Cedars M, Rosen M. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril 2013;100:1673–80